HYPERURICEMIA AND ITS CORRELATES IN THE RUSSIAN POPULATION (RESULTS OF ESSE-RF EPIDEMIOLOGICAL STUDY)

HYPERURICEMIA AND ITS CORRELATES IN THE RUSSIAN POPULATION (RESULTS OF ESSE-RF EPIDEMIOLOGICAL STUDY)

Show other versions (1)

<p>Aim. To study the prevalence of hyperuricemia in the Russian regions, depending on the climatic, geographical, socio-demographic characteristics and some cardiometabolic risk factors.</p><p>Material and methods. Data from the ESSE-RF study from 10 regions of theRussian Federatio...

Full description

Bibliographic Details
Main Authors:	S. A. Shalnova, A. D. Deev, G. V. Artamonov, D. V. Duplyakov, A. Yu. Efanov, Yu. V. Zhernakova, A. O. Konradi, R. A. Libis, G. A. Muromtseva, S. V. Nedogoda, E. V. Oschepkova, S. V. Romanchuk, O. P. Rotar, V. N. Titov, Z. A. Toguzova, I. A. Trubacheva, G. I. Furmenko, E. V. Shlyakhto, S. A. Boytsov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	мочевая кислота распространенность гиперурикемия сердечно-сосудистые заболевания пол возраст факторы риска
Online Access:	http://www.rpcardio.ru/jour/article/view/16

Similar Items

NEW OPPORTUNITIES FOR CORRECTION OF HYPERURICEMIA IN GOUT
by: Svetlana Evgenyevna Myasoedova, et al.
Published: (2009-12-01)

USE OF HERBAL REMEDY URISAN AS BASIC THERAPY FOR GOUT
by: Tamila Nilovna Khalfina, et al.
Published: (2010-06-01)

Risk factors for type 2 diabetes mellitus in patients with gout: results from a prospective study
by: O. V. Zhelyabina, et al.
Published: (2022-02-01)

Asymptomatic hyperuricemia as a component of metabolic syndrome
by: I. D. Bespalova, et al.
Published: (2012-06-01)

HYPERURICEMIA AND ITS CORRELATES IN THE RUSSIAN POPULATION (RESULTS OF ESSE-RF EPIDEMIOLOGICAL STUDY)
by: S. A. Shalnova, et al.
Published: (2015-09-01)

VALUE OF THE PHYTODRUGS PROLIT AND URISAN IN THE TREATMENT OF GOUTY PATIENTS
by: A E Ilyina, et al.
Published: (2010-09-01)

THE HERBAL COMPLEX URISAN IS THE HELP TO A PHYSICIAN TREATING A PATIENT WITH GOUT
by: I I Polskaya, et al.
Published: (2009-09-01)

ВЗАИМОСВЯЗИ ГИПЕРУРИКЕМИИ И ГИПЕРЛИПИДЕМИИ У МУЖЧИН С ПЕРВИЧНОЙ ПОДАГРОЙ
by: D. A. Nabiyeva, et al.
Published: (2016-05-01)

Comments on the updated recommendations of the American College of Rheumatology (ACR) for the treatment of gout. Lifestyle (part 2)
by: M. S. Eliseev
Published: (2021-04-01)

THE PREVALENCE OF ELEVATED LEVELS OF C-REACTIVE PROTEIN AND ITS ASSOCIATION WITH TRADITIONAL RISK FACTORS AND MORBIDITY AMONG RESIDENTS OF THE RUSSIAN FEDERATION (ACCORDING TO THE ESSE-RF STUDY)
by: S. E. Evstifeeva, et al.
Published: (2015-09-01)

Chronic kidney disease: the role of hyperuricemia and the possibility of urate-lowering therapy
by: M. S. Eliseev
Published: (2018-04-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
by: R. M. Balabanova, et al.
Published: (2021-06-01)

Losartan therapy and hyperuricemia correction in patients with metabolic syndrome and arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2011-12-01)

ARTERIAL HYPERTENSION AMONG INDIVIDUALS OF 25–64 YEARS OLD: PREVALENCE, AWARENESS, TREATMENT AND CONTROL. BY THE DATA FROM ECCD
by: S. A. Boytsov, et al.
Published: (2014-08-01)

Prevalence of non-alcoholic fatty liver disease among the working-age population: associations with socio-demographic indicators and behavioral risk factors (ESSE RF-2 data)
by: S. E. Evstifeeva, et al.
Published: (2022-10-01)

THE PREVALENCE OF ELEVATED LEVELS OF C-REACTIVE PROTEIN AND ITS ASSOCIATION WITH TRADITIONAL RISK FACTORS AND MORBIDITY AMONG RESIDENTS OF THE RUSSIAN FEDERATION (ACCORDING TO THE ESSE-RF STUDY)
by: S. E. Evstifeeva, et al.
Published: (2015-09-01)

USE OF URISAN IN PATIENTS WITH GOUT
by: L A Knyazeva, et al.
Published: (2010-03-01)

Current ideas on the pathogenesis of uric acid nephrolithiasis and its correction methods in gouty patients
by: V G Barskova, et al.
Published: (2011-12-01)

Microbiota as a new pathogenetic factor in the development of chronic hyperuricemia and gout. Part I: the current state of the problem
by: M. S. Eliseev, et al.
Published: (2022-10-01)

THE ASSOCIATION OF DEPRESSION WITH C-REACTIVE PROTEIN (THE DATA OF ESSE-RF EPIDEMIOLOGICAL STUDY)
by: S. E. Evstifeeva, et al.
Published: (2016-05-01)

THE PREVALENCE OF NON-INFECTIOUS DISEASES RISK FACTORS IN RUSSIAN POPULATION IN 2012-2013 YEARS. THE RESULTS OF ECVD-RF
by: G. A. Muromtseva, et al.
Published: (2014-12-01)

Prevalence of hyperuricemia in professional athletes and its role in the genesis of various pathological conditions and metabolic disturbances
by: M. S. Eliseev, et al.
Published: (2018-09-01)

Prevalence of hypotension in populations of the Russian Federation and the United States of America according to 30-year follow-up
by: V. G. Vilkov, et al.
Published: (2020-07-01)

Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation (ESSE-RF) study. Ten years later
by: S. A. Boytsov, et al.
Published: (2021-09-01)

Specific features of systemic lupus erythematosus in males: case reports and literature data
by: Natalia Gennadyevna Klyukvina, et al.
Published: (2013-12-01)

LEVEL OF URIC ACID IN BLOOD SERUM OF NEW PULMONARY TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: R. Yu. Аbdullaev, et al.
Published: (2017-04-01)

THE COURSE OF GOUTY ARTHRITIS ACCORDING TO THE KHABAROVSK CITY RHEUMATOLOGY ROOMAND THE EFFECTIVENESS OF GOUT SCHOOL
by: Faina Sergeyevna Zharskaya, et al.
Published: (2010-06-01)

C-reactive protein and sociodemographic parameters in Moscow residents aged 55 years and older
by: S. A. Shalnova, et al.
Published: (2011-12-01)

РАСПРЕДЕЛЕНИЕ ГЕНОТИПОВ ГЕНА SLC2A9, УРОВЕНЬ МОЧЕВОЙ КИСЛОТЫ И МЕТАБОЛИТЫ ПУРИНОВОГО ОБМЕНА У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ И ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ
by: Т. Л. Борисенко, et al.
Published: (2024-03-01)

DIABETES RISK AND ASSOCIATIONS WITH DEMOGRAPHIC AND BEHAVIORAL FACTORS IN RUSSIAN POPULATION: DATA FROM THE ESSE-RF STUDY
by: S. E. Evstifeeva, et al.
Published: (2017-10-01)

Correction of hyperuricemia in metabolic syndrome
by: S. V. Nedogoda, et al.
Published: (2014-12-01)

The use of febuxostat in comorbid patients with gout in real clinical practice: own data
by: E. V. Zonova, et al.
Published: (2022-06-01)

COMPLAINTS ON SLEEP BREATHING DISORDER AND CARDIOVASCULAR RISK FACTORS IN RUSSIAN REGIONS: DATA FROM ESSE-RF STUDY
by: M. V. Bochkarev, et al.
Published: (2018-07-01)

Prevalence of comorbidities and their influence on complications and outcomes of coronary bypass surgery for coronary heart disease in gender perspective
by: E. B. Klester, et al.
Published: (2016-04-01)

Is the population level of anxiety and depression associated with mortality? Data from the ESSE-RF study
by: S. E. Evstifeeva, et al.
Published: (2021-09-01)

Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
by: Maksim Sergeyevich Eliseyev, et al.
Published: (2012-09-01)

The prevalence of electrocardiographic abnormalities in the Russian population in the early 21st century (the ESSE-RF study)
by: G. A. Muromtseva, et al.
Published: (2018-12-01)

Gender-specific features of psychosocial status and their clinical effects in myocardial infarction patients
by: N. B. Lebedeva, et al.
Published: (2007-02-01)

GENDER CHARACTERISTICS OF ADVERSE DRUG REACTIONS DEVELOPMENT: EXPERIENCE OF REGIONAL DATABASE ANALYSIS
by: A. V. Matveev, et al.
Published: (2022-05-01)

Uric acid metabolic disorders in children with acute infectious diarrhea
by: S. V. Khaliullina, et al.
Published: (2016-03-01)